Sixteenth Starr Cancer Consortium Grant Competition

Competing Project Renewal Awards

  • Mechanisms of dynamic chromatin reorganization regulating B-cell differentiation and Lymphomagenesis

    Principal Investigator: 

      • Steven Josefowicz, PhD - Weill Cornell Medicine

    Co-Principal Investigators:

      • Christina Leslie, PhD - Memorial Sloan Kettering Cancer Center
        • Ari Melnick, MD - Weill Cornell Medicine
          • Shixin Liu, PhD - The Rockefeller University

          Abstract

New Awards

  • Determining and targeting evolutionary trajectories driving bladder cancer

    Principal Investigator:

      • Dawid Nowak, PhD - Weill Cornell Medicine

    Co-Principal Investigators:

      • David Solit, MD - Memorial Sloan Kettering Cancer Center
        • Adam Siepel, PhD - Cold Spring Harbor Laboratory

        Abstract 
  • Defining the gene regulatory response and pathways for acquired resistance to CDK inhibitor treatment in hormone receptor positive breast cancer

    Principal Investigator:

      • Viviana Risca, PhD - The Rockefeller University

    Co-Principal Investigators:

      • Sarat Chandarlapaty, MD, PhD - Memorial Sloan Kettering Cancer Center
        • Andrew Koff, PhD - Memorial Sloan Kettering Cancer Center

        Abstract 
  • Defining the role of stress-induced changes in the IgG-gut microbiome-neutrophil axis during breast cancer progression and metastasis

    Principal Investigator:

      • Melody Zeng, PhD - Weill Cornell Medicine

    Co-Principal Investigators:

      • Irina Matei, PhD - Weill Cornell Medicine
        • Mikala Egeblad, PhD - Cold Spring Harbor Laboratory

        Abstract
  • Identifying acquired vulnerabilities driven by lineage plasticity and drug resistance in CRC

    Principal Investigator:

      • Lukas Dow, PhD - Weill Cornell Medicine

    Co-Principal Investigator:

      • Karuna Ganesh, MD, PhD - Memorial Sloan Kettering Cancer Center
      Abstract 
  • Sequestration of transcriptional regulators by the lenalidomide–cereblon complex for targeting myeloid leukemia

    Principal Investigator:

      • Christina Woo, PhD - The Broad Institute of MIT and Harvard

    Co-Principal Investigator:

      • Michael Kharas, PhD - Memorial Sloan Kettering Cancer Center
      Abstract 
  • Targeting cytidine deaminase-induced chromosomal instability as a driver of metastasis in bladder cancer

    Principal Investigator:

      • Bishoy Faltas, MD - Weill Cornell Medicine

    Co-Principal Investigators:

      • Samuel Bakhoum, MD, PhD - Memorial Sloan Kettering Cancer Center
        • Vivek Mittal, PhD - Weill Cornell Medicine
        Abstract 
  • The influence of homologous recombination deficiency on tumor immunity and immunotherapy efficacy

    Principal Investigator:

      • Nadeem Riaz, MD - Memorial Sloan Kettering Cancer Center

    Co-Principal Investigators:

      • Jorge Reis-Filho, MD, PhD - Memorial Sloan Kettering Cancer Center
        • Lorenzo Galluzzi, PhD - Weill Cornell Medicine

        Abstract